(Q46592044)

English

Cardiovascular safety and overall tolerability of solifenacin in routine clinical use: a 12-week, open-label, post-marketing surveillance study

scientific article published in January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484784

Cardiovascular safety and overall tolerability of solifenacin in routine clinical use: a 12-week, open-label, post-marketing surveillance study (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484784

circulatory system

1 reference

based on heuristic

inferred from title

author name string

Martin C Michel

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484784

Ulrich Wetterauer

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484784

Monika Vogel

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484784

Jean J M C H de la Rosette

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484784

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484784

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484784

31

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484784

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484784

505-514

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484784

A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200831060-00005

21 January 2018

Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Solifenacin in overactive bladder syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and burden of overactive bladder in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Muscarinic receptor density in the rat urinary bladder after denervation, hypertrophy and urinary diversion

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenergic and muscarinic receptors in the human heart

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In primary neuronal cultures muscarinic m1 and m3 receptor mRNA levels are regulated by agonists, partial agonists and antagonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment satisfaction of patients with lower urinary tract symptoms: randomised controlled trials vs. real life practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does gender or age affect the efficacy and safety of tolterodine?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resting heart rate in cardiovascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/18484784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002018-200831060-00005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484784

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18484784

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46592044&oldid=2207965391"